0.1864 USD
+0 (+0.59%)
0.17 USD
-0.02 (-8.8%)
ChartMill assigns a Buy % Consensus number of 43% to BXRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 24.48. This target is 13033.05% above the current price.
BXRX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about BXRX.
In the previous month the buy percentage consensus was at a similar level.
BXRX was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-01-03 | Noble Capital Markets | Downgrade | Outperform -> Market Perform |
BAUDAX BIO INC / BXRX FAQ
What is the average price target for BAUDAX BIO INC (BXRX) stock?
6 analysts have analysed BXRX and the average price target is 24.48 USD. This implies a price increase of 13033.05% is expected in the next year compared to the current price of 0.1864.
What is the consensus rating for BAUDAX BIO INC (BXRX) stock?
The consensus rating for BAUDAX BIO INC (BXRX) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts have analysed BAUDAX BIO INC (BXRX)?
The number of analysts covering BAUDAX BIO INC (BXRX) is 6.